Shopping Cart
Remove All
Your shopping cart is currently empty
LTF4 is a cysteinyl-leukotriene produced in vitro, but not reported to date in vivo. It is formed by the incubation of LTE4 with γ-glutamyl transpeptidase and glutathione. LTF4 is a weak agonist in its ability to contract vascular smooth muscle. [1] The rank order of potency of the cysteinyl-leukotrienes to contract vascular smooth muscle is LTD4 > LTC4 > LTE4 >> LTF4. [1] [2]

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 μg | $482 | 35 days | 35 days | |
| 50 μg | $892 | 35 days | 35 days | |
| 100 μg | $1,680 | 35 days | 35 days |
| Description | LTF4 is a cysteinyl-leukotriene produced in vitro, but not reported to date in vivo. It is formed by the incubation of LTE4 with γ-glutamyl transpeptidase and glutathione. LTF4 is a weak agonist in its ability to contract vascular smooth muscle. [1] The rank order of potency of the cysteinyl-leukotrienes to contract vascular smooth muscle is LTD4 > LTC4 > LTE4 >> LTF4. [1] [2] |
| Synonyms | LTF4 |
| Molecular Weight | 568.72 |
| Formula | C28H44N2O8S |
| Cas No. | 83851-42-7 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMF: >50 mg/mL (per Ramki Iyer), Sonication is recommended. Ethanol: >50 mg/mL (per Ramki Iyer), Sonication is recommended. DMSO: >50 mg/mL (per Ramki Iyer), Sonication is recommended. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.